Dr. Heather Wheeler, DO
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,745 | 494 | 99.6% |
| Education | $22.68 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $969.00 | 111 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $692.62 | 90 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $659.68 | 42 | $0 (2024) |
| ABBVIE INC. | $621.28 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $434.45 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $386.77 | 42 | $0 (2022) |
| Novo Nordisk Inc | $297.39 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $280.89 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $256.89 | 27 | $0 (2021) |
| Amgen Inc. | $200.57 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $418.39 | 23 | ABBVIE INC. ($228.08) |
| 2023 | $531.79 | 29 | AbbVie Inc. ($277.73) |
| 2022 | $281.48 | 18 | ABBVIE INC. ($92.37) |
| 2021 | $433.14 | 30 | PFIZER INC. ($85.12) |
| 2020 | $136.98 | 10 | Genentech USA, Inc. ($34.54) |
| 2019 | $777.93 | 73 | PFIZER INC. ($192.20) |
| 2018 | $1,451 | 132 | AstraZeneca Pharmaceuticals LP ($331.61) |
| 2017 | $1,737 | 183 | Janssen Pharmaceuticals, Inc ($354.83) |
All Payment Transactions
498 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: PAIN | ||||||
| 11/20/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: VACCINES | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: VACCINES | ||||||
| 08/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Obesity | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: VACCINES | ||||||
| 05/07/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Hepatitis B Vaccine | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Biological | ||||||
| 02/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: VACCINES | ||||||
| 02/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 870 | 1,222 | $257,400 | $102,202 |
| 2022 | 13 | 906 | 1,262 | $240,432 | $101,261 |
| 2021 | 12 | 776 | 1,120 | $210,641 | $73,587 |
| 2020 | 13 | 790 | 1,097 | $189,006 | $64,521 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 527 | $129,096 | $42,769 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 210 | 210 | $47,586 | $25,646 | 53.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 39 | 39 | $22,283 | $10,931 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 131 | $22,663 | $7,081 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 38 | $13,074 | $4,732 | 36.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 57 | 57 | $8,225 | $4,316 | 52.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $2,348 | $1,831 | 78.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,847 | $1,735 | 60.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,061 | $1,537 | 25.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 38 | 38 | $1,126 | $1,028 | 91.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 55 | $1,828 | $523.60 | 28.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 29 | 33 | $263.00 | $72.60 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 540 | $127,406 | $43,399 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 205 | 205 | $42,230 | $25,330 | 60.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 141 | $23,553 | $7,937 | 33.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 28 | 28 | $15,876 | $7,800 | 49.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 72 | 74 | $7,770 | $5,176 | 66.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 22 | $7,254 | $2,962 | 40.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 80 | 82 | $2,214 | $2,173 | 98.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $3,952 | $2,045 | 51.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $1,968 | $1,594 | 81.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,417 | $1,248 | 28.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 40 | 40 | $1,080 | $1,065 | 98.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 33 | 45 | $2,160 | $432.33 | 20.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 34 | 46 | $552.00 | $102.05 | 18.5% |
About Dr. Heather Wheeler, DO
Dr. Heather Wheeler, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Edmond, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1124388293.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heather Wheeler, DO has received a total of $5,768 in payments from pharmaceutical and medical device companies, with $418.39 received in 2024. These payments were reported across 498 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,745).
As a Medicare-enrolled provider, Wheeler has provided services to 3,342 Medicare beneficiaries, totaling 4,701 services with total Medicare billing of $341,571. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Edmond, OK
- Active Since 05/23/2012
- Last Updated 07/21/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1124388293
Products in Payments
- XARELTO (Drug) $422.69
- FARXIGA (Drug) $374.18
- EUCRISA (Drug) $330.44
- MYRBETRIQ (Drug) $284.80
- VRAYLAR (Drug) $269.99
- INVOKANA (Drug) $269.93
- JARDIANCE (Drug) $228.36
- JANUVIA (Drug) $197.38
- QULIPTA (Drug) $196.48
- SYMBICORT (Drug) $195.73
- VIBERZI (Drug) $160.17
- Prolia (Biological) $155.68
- PREVNAR 20 (Biological) $145.06
- Saxenda (Drug) $128.40
- Myrbetriq (Drug) $122.03
- LINZESS (Drug) $112.89
- ELIQUIS (Drug) $105.89
- BREO (Drug) $101.50
- TOUJEO (Drug) $99.11
- Ozempic (Drug) $95.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Edmond
Dr. Shea Charbeneau, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $13,355
Mr. Chad Knight, D.p.m, D.P.M
Student in an Organized Health Care Education/Training Program — Payments: $7,378
Dr. Tiffany Mao, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,313
Dr. Andrew John, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,096
Jennifer Li, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,840
Jeremy Edwards, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $1,361